Piper Sandler analyst Jessica Tassan raised the firm’s price target on Phreesia (PHR) to $33 from $31 and keeps an Overweight rating on the ...
In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...
Barclays analyst Balaji Prasad maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) today and set a price target of $28.00.
Barclays analyst Balaji Prasad maintained a Buy rating on Zoetis (ZTS – Research Report) today and set a price target of $242.00. The company’s ...
Analog, the pioneers of blockchain interoperability Proof of Time protocol, has announced the completion of a $5M funding round supported by major venture capital firms. The raise, which brings Analog ...
President Biden awarded the nation’s highest civilian honor to more than a dozen politicians, philanthropists and cultural icons during a ceremony at the White House Saturday. Nineteen people ...
Barclays analyst Balaji Prasad raised the firm’s price target on Tarsus Pharmaceuticals (TARS) to $62 from $60 and keeps an Overweight rating ...
Barclays analyst Balaji Prasad maintained a Hold rating on Pacira Pharmaceuticals (PCRX – Research Report) today and set a price target of ...
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Evolus (EOLS – Research Report), with a price target of ...
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Coherus Biosciences (CHRS – Research Report), with a price ...
Barclays analyst Balaji Prasad maintained a Buy rating on Amneal Pharmaceuticals (AMRX – Research Report) today and set a price target of ...